Global Natural Killer Cells Therapeutics Market Research Report 2024(Status and Outlook)

Global Natural Killer Cells Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Global Natural Killer Cells Therapeutics Market Size was estimated at USD 275.23 million in 2023 and is projected to reach USD 399.34 million by 2029, exhibiting a CAGR of 6.40% during the forecast period.

This report provides a deep insight into the global Natural Killer Cells Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Natural Killer Cells Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Natural Killer Cells Therapeutics market in any manner.

Global Natural Killer Cells Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Affimed

Celgene Corporation

Fate Therapeutics

Fortress Biotech

Glycostem Therapeutics

Innate Pharma

Nantkwest

Nkarta Therapeutics

NKT Therapeutics

Ziopharm Oncology

Market Segmentation (by Type)

NK Cell Therapies

NK Cell Directed Antibodies

Market Segmentation (by Application)

Research Centers & Institutes

Hospitals

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Natural Killer Cells Therapeutics Market

Overview of the regional outlook of the Natural Killer Cells Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Natural Killer Cells Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natural Killer Cells Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cells Therapeutics Segment by Type
1.2.2 Natural Killer Cells Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Natural Killer Cells Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Natural Killer Cells Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Natural Killer Cells Therapeutics Market Competitive Landscape
3.1 Global Natural Killer Cells Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natural Killer Cells Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Natural Killer Cells Therapeutics Sales Sites, Area Served, Product Type
3.6 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
3.6.1 Natural Killer Cells Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natural Killer Cells Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Natural Killer Cells Therapeutics Industry Chain Analysis
4.1 Natural Killer Cells Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Natural Killer Cells Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Natural Killer Cells Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cells Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Natural Killer Cells Therapeutics Price by Type (2019-2024)
7 Natural Killer Cells Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cells Therapeutics Market Sales by Application (2019-2024)
7.3 Global Natural Killer Cells Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
8 Natural Killer Cells Therapeutics Market Segmentation by Region
8.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.2 Global Natural Killer Cells Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Natural Killer Cells Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer Cells Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer Cells Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Affimed
9.1.1 Affimed Natural Killer Cells Therapeutics Basic Information
9.1.2 Affimed Natural Killer Cells Therapeutics Product Overview
9.1.3 Affimed Natural Killer Cells Therapeutics Product Market Performance
9.1.4 Affimed Business Overview
9.1.5 Affimed Natural Killer Cells Therapeutics SWOT Analysis
9.1.6 Affimed Recent Developments
9.2 Celgene Corporation
9.2.1 Celgene Corporation Natural Killer Cells Therapeutics Basic Information
9.2.2 Celgene Corporation Natural Killer Cells Therapeutics Product Overview
9.2.3 Celgene Corporation Natural Killer Cells Therapeutics Product Market Performance
9.2.4 Celgene Corporation Business Overview
9.2.5 Celgene Corporation Natural Killer Cells Therapeutics SWOT Analysis
9.2.6 Celgene Corporation Recent Developments
9.3 Fate Therapeutics
9.3.1 Fate Therapeutics Natural Killer Cells Therapeutics Basic Information
9.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
9.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product Market Performance
9.3.4 Fate Therapeutics Natural Killer Cells Therapeutics SWOT Analysis
9.3.5 Fate Therapeutics Business Overview
9.3.6 Fate Therapeutics Recent Developments
9.4 Fortress Biotech
9.4.1 Fortress Biotech Natural Killer Cells Therapeutics Basic Information
9.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Overview
9.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product Market Performance
9.4.4 Fortress Biotech Business Overview
9.4.5 Fortress Biotech Recent Developments
9.5 Glycostem Therapeutics
9.5.1 Glycostem Therapeutics Natural Killer Cells Therapeutics Basic Information
9.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
9.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Market Performance
9.5.4 Glycostem Therapeutics Business Overview
9.5.5 Glycostem Therapeutics Recent Developments
9.6 Innate Pharma
9.6.1 Innate Pharma Natural Killer Cells Therapeutics Basic Information
9.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Overview
9.6.3 Innate Pharma Natural Killer Cells Therapeutics Product Market Performance
9.6.4 Innate Pharma Business Overview
9.6.5 Innate Pharma Recent Developments
9.7 Nantkwest
9.7.1 Nantkwest Natural Killer Cells Therapeutics Basic Information
9.7.2 Nantkwest Natural Killer Cells Therapeutics Product Overview
9.7.3 Nantkwest Natural Killer Cells Therapeutics Product Market Performance
9.7.4 Nantkwest Business Overview
9.7.5 Nantkwest Recent Developments
9.8 Nkarta Therapeutics
9.8.1 Nkarta Therapeutics Natural Killer Cells Therapeutics Basic Information
9.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
9.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Market Performance
9.8.4 Nkarta Therapeutics Business Overview
9.8.5 Nkarta Therapeutics Recent Developments
9.9 NKT Therapeutics
9.9.1 NKT Therapeutics Natural Killer Cells Therapeutics Basic Information
9.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
9.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product Market Performance
9.9.4 NKT Therapeutics Business Overview
9.9.5 NKT Therapeutics Recent Developments
9.10 Ziopharm Oncology
9.10.1 Ziopharm Oncology Natural Killer Cells Therapeutics Basic Information
9.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
9.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product Market Performance
9.10.4 Ziopharm Oncology Business Overview
9.10.5 Ziopharm Oncology Recent Developments
10 Natural Killer Cells Therapeutics Market Forecast by Region
10.1 Global Natural Killer Cells Therapeutics Market Size Forecast
10.2 Global Natural Killer Cells Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Natural Killer Cells Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region
10.2.4 South America Natural Killer Cells Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Natural Killer Cells Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Natural Killer Cells Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Natural Killer Cells Therapeutics by Type (2025-2030)
11.1.2 Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Natural Killer Cells Therapeutics by Type (2025-2030)
11.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Natural Killer Cells Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Natural Killer Cells Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings